Skip to main content

Amanta Healthcare Ltd

Stage 2 · Advancing · week 13Setup 6.5 ★★ GoodStrong +7.3

Amanta Healthcare Limited operates as a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products and parenteral products in Africa, Latin Am… More about the company

₹207.1
+4.76% today
₹804 Cr · Small cap
Market Neutral — FadingHealth Care 45.7% in Stage 2-1.4 pts / 20dPharmaceuticals 53.8%+3.8 pts
Loading price chart…
vs 52W High
0.0%
₹95 lo₹207.1 hi
Near 52W high
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 13
1w13w26w
Week 13 — proven structure, sweet spot
How long this stock has been in Stage 2. The sweet spot is mid-run — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
49.0%
200 DMA: ₹139 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
3.02x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
→
MA20 flat · +0.4% vs MA50 +5.5%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
+6.7%
3M
+11.1%
6M
+92.6%
YTD
+83.7%
1Y
+49.9%
Sector
Health Care
↓ Peaking
Stage 2%
45.7%
20d Δ
-1.4pp
1M return
-1.8%
3M return
+4.4%
Sector Stage-2 % · last 20 days
This stock ranks #26 of 77 Stage 2 stocks in Health Care by RS.
Industry
Pharmaceuticals
↑ Building
Stage 2%
53.8%
20d Δ
+3.8pp
1M return
-0.9%
3M return
+3.6%
Industry Stage-2 % · last 20 days
Ranks #23 of 61 Stage 2 stocks in this industry.
Stage Cycle Timeline2025-09-11 → 2026-10-07
S? 43w
S2 13w
2025-09-112026-10-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 43w → S2 13w current
Total tracked: 56 weeks across 2 stage runs.
Scan Membership
Prop Scan
Latest: 2026-10-07
60 appearances in last 60 days. First seen: 2026-07-08.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-07S2
Wk 13 · Vol 3.02x
2026-10-06S2
Wk 13 · Vol 1.28x
2026-10-05S2
Wk 13 · Vol 1.24x
2026-10-01S2
Wk 13 · Vol 0.75x
2026-09-30S2
Wk 13 · Vol 0.28x
2026-09-29S2
Wk 12 · Vol 0.57x
2026-09-28S2
Wk 12 · Vol 0.21x
2026-09-25S2
Wk 12 · Vol 0.14x
2026-09-24S2
Wk 12 · Vol 0.35x
2026-09-23S2
Wk 12 · Vol 0.63x
2026-09-22S2
Wk 11 · Vol 0.45x
2026-09-21S2
Wk 11 · Vol 0.57x
Sector Peers — Stage 2All →
KOPRAN
wk 19 · -5.0% from hi
9.0
SMSPHARMA
wk 3 · -3.0% from hi
8.7
KILITCH
wk 2 · -1.7% from hi
8.7
BAFNAPH
wk 17 · 0.0% from hi
8.6
ZIMLAB
wk 21 · 0.0% from hi
8.3
Moving averages & range
50 DMA
₹183.3
200 DMA
₹139
52W High
₹207.1
52W Low
₹95
5D Low
₹190.4
Resistance levels (recent highs)
20d High
₹207.1
60d High
₹207.1
120d High
₹207.1
250d High
₹207.1
Next resistance
Above all
P/E (TTM)
30.4
Forward —
Earnings Growth (YoY)
-23.4%
Revenue +6.8%
ROE
+9.4%
Profit margin +5.2%
About this companyHealth Care· Pharmaceuticals

Amanta Healthcare Limited operates as a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products and parenteral products in Africa, Latin America, the United Kingdom, and internationally. The company manufactures its products in three product group segments Large Volume Parenteral, Nipple Head (Single Port), SteriPort (Two Ports), and Small Volume Parenteral. Additionally, it manufactures medical devices and fluid therapy - (IV Fluid), formulations, diluents, ophthalmic, respiratory care and irrigation solutions in therapeutic segment and products, such as irrigation, first-aid solution, and eye lubricants in medical device segment. It also offers a wide range of closure systems, such as nipple head, twist-off, leur-lock, and screw types and container fill-volume ranging from 2ml to 1000 ml. Its markets its products through three strategic business units including national sales, international sales, and product partnering with various foreign and Indian pharmaceutical companies. Amanta Healthcare Limited was formerly known as Marck Biosciences Limited and changed its name to Amanta Healthcare Limited in June 2014. Amanta Healthcare Limited was incorporated in 1994 and is headquartered in Ahmedabad, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.